Sophia Genetics, a data-driven medicine company backed by British entrepreneur Mike Lynch, has raised $15 million of new funding from investors including Omega Pharma founder Marc Coucke to grow its genetic analysis platform.
Perrigo Company plc Ordinary Shares (NYSE: PRGO) recently completed its acquisition of Omega Pharma Invest N.V.
Perrigo CEO Joseph Papa was on CNBC Monday to discuss the benefits of the deal and Perrigo's move to Ireland.
Shares of Perrigo Company plc (NYSE: PRGO) surged higher Thursday amid reports that the company will buy Omega Pharma NV.
Bloomberg reported that "Perrigo Co. has entered exclusive talks to buy Omega Pharma NV after beating suitors including...
Lately, OTC businesses have been selling like hotcakes, with a number of global consumer players looking to bulk up. Now, reports say Belgium's Omega Pharma could be the next to enter the deal arena with an OTC business worth more than $4 billion.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.